Skip to main content
Log in

Clinical and magnetic resonance evolution of “infarct-like” myocarditis

  • Cardiac radiology
  • Published:
La radiologia medica Aims and scope Submit manuscript

Abstract

Aims

To analyse the clinical and magnetic resonance evolution of myocarditis in patients with an “infarct-like” presentation pattern.

Methods

The study is a retrospective analysis of 52 patients with clinical diagnosis of “infarct-like” myocarditis confirmed by CMR as acute myocarditis according to Lake Louise criteria and 6 months follow-up. The CMR protocol included T2-weighted (oedema), early (hyperaemia) and late (fibrosis/necrosis) gadolinium enhancement sequences, according to Lake Louise criteria. Clinical and radiological follow-up by CMR was performed after a median time interval of 6 months (interquartile range 5–8). Quantitative outcomes were checked for normality and compared with the non-parametric Wilcoxon’s test for matched data.

Results

At the clinical follow-up all patients were free of symptoms and reported no cardiac complications. The CMR follow-up evidenced a significant increase of the ejection fraction (from 53 ± 6 to 55 ± 4%, p = 0.03), a decrease of the ventricular mass [from 67.0 (58.8–79.0) to 61.0 (54.0–67.0), p < 0.0001] without significant modification of the cardiac volume index (p = 0.26). No patient had residual oedema or capillary leakage: the T2 ratio decreased from 3.94 (3.00–4.86) to 0.98 (0.75–1.17) with p < 0.0001 and the Early gadolinium enhancement (EGE) ratio from 5.7 (4.8–6.5) to 2.9 (2.4–3.2) with p < 0.0001. Late gadolinium enhancement (LGE) persisted over the course of the follow-up in 48/52 patients, but with a significant reduction in every patient (LGE % from 34.3 ± 9.1 to 19.4 ± 6.6%; p < 0.0001).

Conclusion

Patients diagnosed with “infarct-like” myocarditis, according to both clinical and CMR examinations may look forward to a positive evolution with a good prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dennert R, Crijns HJ, Heymans S (2008) Acute viral myocarditis. Eur Heart J 29(17):2073–2082

    Article  PubMed  PubMed Central  Google Scholar 

  2. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT et al (2009) Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol 53(17):1475–1487

    Article  PubMed  PubMed Central  Google Scholar 

  3. Di Cesare E, Cademartiri F, Carbone I, Carriero A, Centonze M, De Cobelli F et al (2013) Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging. Radiol Med 118(5):752–798

    Article  PubMed  Google Scholar 

  4. Francone M, Chimenti C, Galea N, Scopelliti F, Verardo R, Galea R et al (2014) CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. JACC Cardiovasc Imaging 7(3):254–263

    Article  PubMed  Google Scholar 

  5. Francone M, Cesare ED, Cademartiri F, Pontone G, Lovato L, Matta G et al (2014) Italian registry of cardiac magnetic resonance. Eur J Radiol 83(1):e15–e22

    Article  PubMed  Google Scholar 

  6. Danti M, Sbarbati S, Alsadi N, Di Filippo A, Gangitano G, Giglio L et al (2009) Cardiac magnetic resonance imaging: diagnostic value and utility in the follow-up of patients with acute myocarditis mimicking myocardial infarction. Radiol Med 114(2):229–238

    Article  CAS  PubMed  Google Scholar 

  7. Zagrosek A, Abdel-Aty H, Boyé P, Wassmuth R, Messroghli D, Utz W et al (2009) Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging 2(2):131–138

    Article  PubMed  Google Scholar 

  8. Stensaeth KH, Hoffmann P, Fossum E, Mangschau A, Sandvik L, Klow NE (2012) Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis. Int J Cardiovasc Imaging 28(2):327–335

    Article  PubMed  Google Scholar 

  9. De Stefano L, Perez de Arenaza D, Yeyati EL, Pietrani M, Kohan A, Falconi M et al (2014) Low rate of cardiovascular events in patients with acute myocarditis diagnosed by cardiovascular magnetic resonance. Cardiovasc Diagn Ther 4(2):64–70

    PubMed  PubMed Central  Google Scholar 

  10. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G et al (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114(15):1581–1590

    Article  PubMed  Google Scholar 

  11. Grün S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O et al (2012) Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 59(18):1604–1615

    Article  PubMed  Google Scholar 

  12. Schumm J, Greulich S, Wagner A, Grün S, Ong P, Bentz K et al (2014) Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson 16(1):14

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sanguineti F, Garot P, Mana M, O’h-Ici D, Hovasse T, Unterseeh T et al (2015) Cardiovascular magnetic resonance predictors of clinical outcome in patients with suspected acute myocarditis. J Cardiovasc Magn Reson 17(1):78

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chopra H, Arangalage D, Bouleti C, Zarka S, Fayard F, Chillon S et al (2016) Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. Int J Cardiol 212:63–69

    Article  PubMed  Google Scholar 

  15. Caforio ALP, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S et al (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28(11):1326–1333

    Article  PubMed  Google Scholar 

  16. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bültmann B, Müller T et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118(6):639–648

    Article  PubMed  Google Scholar 

  17. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al (2006) Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48(10):1977–1985

    Article  PubMed  Google Scholar 

  18. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert E-M et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):875–887

    Article  PubMed  Google Scholar 

  19. Monney PA, Sekhri N, Burchell T, Knight C, Davies C, Deaner A et al (2011) Acute myocarditis presenting as acute coronary syndrome: role of early cardiac magnetic resonance in its diagnosis. Heart Br Card Soc 97(16):1312–1318

    Article  Google Scholar 

  20. Schwab J, Rogg H-J, Pauschinger M, Fessele K, Bareiter T, Bär I et al (2015) Functional and morphological parameters with tissue characterization of cardiovascular magnetic imaging in clinically verified ‘infarct-like myocarditis’. Rofo 188(4):365–373

    Article  PubMed  Google Scholar 

  21. Esposito A, Francone M, Faletti R, Centonze M, Cademartiri F, Carbone I et al (2016) Lights and shadows of cardiac magnetic resonance imaging in acute myocarditis. Insights Imaging 7(1):99–110

    Article  PubMed  Google Scholar 

  22. Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG et al (2013) Standardized image interpretation and post processing in cardiovascular magnetic resonance: society for cardiovascular magnetic resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 15:35

    Article  PubMed  PubMed Central  Google Scholar 

  23. Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NAM et al (2015) Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 132(22):e273–e280

    Article  PubMed  Google Scholar 

  24. Anzini M, Merlo M, Sabbadini G, Barbati G, Finocchiaro G, Pinamonti B et al (2013) Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation 128(22):2384–2394

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marco Gatti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standards

This article does not contain any studies with human participants or animals performed by any of the authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Faletti, R., Gatti, M., Baralis, I. et al. Clinical and magnetic resonance evolution of “infarct-like” myocarditis. Radiol med 122, 273–279 (2017). https://doi.org/10.1007/s11547-016-0723-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11547-016-0723-5

Keywords

Navigation